+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 40Years - 70Years
All Genders
ID06069518

Continuous Glucose Monitoring to Improve Metabolic Control in Patients With Diabetes Undergoing Peritoneal Dialysis at IMSS

Led by Coordinación de Investigación en Salud, Mexico · Updated on 2026-10-21

110

Participants Needed

2

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Patients with chronic kidney disease caused by type 2 diabetes often face metabolic challenges, including high blood sugar levels and related heart complications. Managing these problems is difficult during peritoneal dialysis because glucose from dialysis fluids affects insulin needs. This study aims to use continuous glucose monitoring to understand how different insulin types, doses, routes, and timing relate to blood sugar patterns, including high and low sugar episodes over 24-hour periods. This observational study involves adults aged 40 to 70 with diabetic nephropathy who are insulin-dependent and have been on automated peritoneal dialysis for at least three months. Participants will wear a Guardian 3 glucose sensor placed under the skin on their non-dominant arm for two consecutive seven-day periods. Data is collected every five minutes and transmitted continuously to a connected smartphone app. On day 14, additional dialysis fluid measurements and dietary information will be collected along with insulin usage records. Participants will be trained to use the glucose monitor and undergo blood tests for standard biochemical markers. Researchers will analyze glucose data to classify participants according to how much time their glucose levels remain within a target range. Statistical methods will identify associations between insulin regimens and glucose control. The study involves minimal risk, includes regular data audits, and participation lasts for 14 days with ongoing monitoring through the continuous glucose sensors.

CONDITIONS

Brief Title

Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis

Research Team

M

Miguel Angel Cuevas Budhart A Cuevas-Budhart, MSc, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here